Englewood, Colo. – Baxa Corporation announces the availability of a compre-hensive new
reference tool for understanding the compliance requirements for sterile compounding and
USP <797> compliance.  The interactive reference map was developed by ClinicalIQ, LLC,
®.  
CriticalPoint, LLC and the National Association of Boards of Pharmacy The tool offers state-
specific guidelines on professional licensing and training requirements, State Board of
Pharmacy harmonization with USP <797> guidelines and sterile compounding laws.

Read full announcement here.  (pdf)